FREE Account Opening + No Clearing Fees
Loading...

Eris Lifesciences IPO vs IndiGrid InvIT Fund

Comparision between Eris Lifesciences IPO and IndiGrid InvIT Fund.

IPO Details

Eris Lifesciences IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while IndiGrid InvIT Fund is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Eris Lifesciences IPO is up to ₹1,741.16 Cr whereas the issue size of the IndiGrid InvIT Fund is up to ₹2,250.00 Cr. The final issue price of Eris Lifesciences IPO is ₹603.00 per share and of IndiGrid InvIT Fund is ₹100.00 per share.

  Eris Lifesciences IPO IndiGrid InvIT Fund
Face Value ₹1 per share ₹100 per share
Issue Price (Lower) ₹600.00 per share ₹98.00 per share
Issue Price (Upper) ₹603.00 per share ₹100.00 per share
Issue Price (Final) ₹603.00 per share ₹100.00 per share
Discount (Retail)
Discount (Employee) ₹60.00 per share
Market Lot Size 24 shares 10205 shares
Fresh Issue Size
Fresh Issue Size (Amount)
OFS Issue Size 2,88,75,000 shares
OFS Issue Size (Amount)
Issue Size Total 2,88,75,000 shares 22,50,00,000 shares
Issue Size Total (Amount) up to ₹1,741.16 Cr up to ₹2,250.00 Cr

IPO Timetable

Eris Lifesciences IPO opens on Jun 16, 2017, while IndiGrid InvIT Fund opens on May 17, 2017. The closing date of Eris Lifesciences IPO and IndiGrid InvIT Fund is Jun 20, 2017, and May 19, 2017, respectively.

  Eris Lifesciences IPO IndiGrid InvIT Fund
Anchor Bid Date
Issue Open Jun 16, 2017 May 17, 2017
Issue Close Jun 20, 2017 May 19, 2017
Basis Of Allotment (Tentative) Jun 23, 2017
Initiation of Refunds (Tentative) Jun 27, 2017
Credit of Share (Tentative) Jun 28, 2017
Listing date (Tentative) Jun 29, 2017
Anchor Lockin End date 1 Jul 23, 2017
Anchor Lockin End date 2 Sep 21, 2017

Financials

Eris Lifesciences IPO P/E ratio is , as compared to IndiGrid InvIT Fund P/E ratio of .

  Eris Lifesciences IPO IndiGrid InvIT Fund
Financial
Summary of financial Information (Consolidated)
Particulars For the year/period ended (in Rs. Million)
31-Mar-16 31-Mar-15 31-Mar-14 31-Mar-13 31-Mar-12
Total Assets 3,973.59 3,572.85 2,705.99 1,718.05 1,019.67
Total Revenue 5,970.21 5,455.58 5,088.22 3,930.64 2,739.40
Profit After Tax 1,348.58 892.59 709.12 584.40 370.63
Promoter Shareholding (Pre-Issue)
Promoter Shareholding (Post-Issue)
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Eris Lifesciences IPO retail investors (RII) are offered 28,72,500 shares while in IndiGrid InvIT Fund retail investors are offered 28,72,500 shares. Qualified institutional buyers (QIB) are offered 86,17,500 shares in Eris Lifesciences IPO and 6,88,80,294 shares in IndiGrid InvIT Fund.

  Eris Lifesciences IPO IndiGrid InvIT Fund
Anchor Investor Reserveration
Market Maker Reserveration
QIB 86,17,500 shares 6,88,80,294 shares
NII 43,08,750 shares
RII 28,72,500 shares
Employee 1,50,000 shares
Others
Total 1,59,48,750 shares 12,62,78,838 shares

Bids Received (Subscription)

Eris Lifesciences IPO subscribed 3.29x in total, whereas IndiGrid InvIT Fund subscribed 1.35x.

  Eris Lifesciences IPO IndiGrid InvIT Fund
QIB (times) 4.68x 1.14x
NII (times) 0.45x
Big NII (times)
Small NII (times)
RII (times) 3.51x
Employee (times) 0.86x
Other (times) 1.60x
Total (times) 3.29x 1.35x

Comments

Add a public comment...